Thanks. I was actually on the first link earlier today. The second is interesting, have not seen that before. We've seen multiple articles about abuse deterrent generics being highly desired these days... Have any even been filed that we know of?
My bet is that we'd also receive priority review for any filed ANDAs given the current spotlight on the opioid problem.
News 
Market Data 
Discover 
